温州医科大学学报
溫州醫科大學學報
온주의과대학학보
Journal of Wenzhou Medical University
2015年
2期
95-99,105
,共6页
刘巧琼%涂建欣%林晓云%熊一融%朱珊丽%陈韶%张丽芳
劉巧瓊%塗建訢%林曉雲%熊一融%硃珊麗%陳韶%張麗芳
류교경%도건흔%림효운%웅일융%주산려%진소%장려방
沙眼衣原体%主要外膜蛋白%原核表达%免疫原性
沙眼衣原體%主要外膜蛋白%原覈錶達%免疫原性
사안의원체%주요외막단백%원핵표체%면역원성
Chlamydia trachomatis%major outer memberane protein%prokaryotic expression%immunogenicity
目的:探讨沙眼衣原体(Ct)E血清型主要外膜蛋白(MOMP21-387)的原核表达及其免疫原性。方法:利用PCR方法扩增Ct E血清型MOMP第21至第387氨基酸的基因序列,克隆至pET21a(+)原核表达载体构建重组质粒pET21a(+)/MOMP21-387,并进行原核表达和纯化,经SDS-PAGE和Western blot法分析鉴定后,通过BALB/c小鼠免疫检测MOMP21-387蛋白的免疫原性,即通过ELISA法检测小鼠血清IgG和生殖道分泌物IgA抗体反应,乳酸脱氢酶(LDH)法检测其脾细胞的特异性杀伤作用。结果:在原核表达系统成功表达了MOMP21-387融合蛋白,经SDS-PAGE及Western blot法鉴定在相对分子质量(Mr)约44000处出现特异性条带;并经Ni-NTA亲和层析的方法获得了纯化的MOMP21-387融合蛋白,免疫BALB/c小鼠可诱导产生特异性血清IgG抗体和生殖道分泌物IgA抗体,至第6周达到高峰,MOMP21-387组的IgG和IgA抗体较PBS组差异均有统计学意义(P<0.05);LDH检测结果显示,MOMP21-387组小鼠脾细胞对靶细胞的杀伤率,在10:1、20:1和40:1和80:1时均明显高于PBS组,差异有统计学意义(P<0.05)。结论:Ct E型MOMP21-387融合蛋白具有良好的免疫原性,为基于MOMP21-387的Ct的ELISA法检测方法的开发和疫苗研究奠定了基础。
目的:探討沙眼衣原體(Ct)E血清型主要外膜蛋白(MOMP21-387)的原覈錶達及其免疫原性。方法:利用PCR方法擴增Ct E血清型MOMP第21至第387氨基痠的基因序列,剋隆至pET21a(+)原覈錶達載體構建重組質粒pET21a(+)/MOMP21-387,併進行原覈錶達和純化,經SDS-PAGE和Western blot法分析鑒定後,通過BALB/c小鼠免疫檢測MOMP21-387蛋白的免疫原性,即通過ELISA法檢測小鼠血清IgG和生殖道分泌物IgA抗體反應,乳痠脫氫酶(LDH)法檢測其脾細胞的特異性殺傷作用。結果:在原覈錶達繫統成功錶達瞭MOMP21-387融閤蛋白,經SDS-PAGE及Western blot法鑒定在相對分子質量(Mr)約44000處齣現特異性條帶;併經Ni-NTA親和層析的方法穫得瞭純化的MOMP21-387融閤蛋白,免疫BALB/c小鼠可誘導產生特異性血清IgG抗體和生殖道分泌物IgA抗體,至第6週達到高峰,MOMP21-387組的IgG和IgA抗體較PBS組差異均有統計學意義(P<0.05);LDH檢測結果顯示,MOMP21-387組小鼠脾細胞對靶細胞的殺傷率,在10:1、20:1和40:1和80:1時均明顯高于PBS組,差異有統計學意義(P<0.05)。結論:Ct E型MOMP21-387融閤蛋白具有良好的免疫原性,為基于MOMP21-387的Ct的ELISA法檢測方法的開髮和疫苗研究奠定瞭基礎。
목적:탐토사안의원체(Ct)E혈청형주요외막단백(MOMP21-387)적원핵표체급기면역원성。방법:이용PCR방법확증Ct E혈청형MOMP제21지제387안기산적기인서렬,극륭지pET21a(+)원핵표체재체구건중조질립pET21a(+)/MOMP21-387,병진행원핵표체화순화,경SDS-PAGE화Western blot법분석감정후,통과BALB/c소서면역검측MOMP21-387단백적면역원성,즉통과ELISA법검측소서혈청IgG화생식도분비물IgA항체반응,유산탈경매(LDH)법검측기비세포적특이성살상작용。결과:재원핵표체계통성공표체료MOMP21-387융합단백,경SDS-PAGE급Western blot법감정재상대분자질량(Mr)약44000처출현특이성조대;병경Ni-NTA친화층석적방법획득료순화적MOMP21-387융합단백,면역BALB/c소서가유도산생특이성혈청IgG항체화생식도분비물IgA항체,지제6주체도고봉,MOMP21-387조적IgG화IgA항체교PBS조차이균유통계학의의(P<0.05);LDH검측결과현시,MOMP21-387조소서비세포대파세포적살상솔,재10:1、20:1화40:1화80:1시균명현고우PBS조,차이유통계학의의(P<0.05)。결론:Ct E형MOMP21-387융합단백구유량호적면역원성,위기우MOMP21-387적Ct적ELISA법검측방법적개발화역묘연구전정료기출。
Objective:To explore prokaryotic expression and immunogenicity of major outer membrane protein (MOMP21-387) of Chlamydia trachomatis serotype E. Methods:The gene encoding MOMP21-387 was ampliifed from genome DNA of C. trachomatis E by PCR analysis, and then cloned into pET21a (+) vector to construct recombinant plasmid pET21a (+)/MOMP21-387, and was expressed in the prokaryotic expression system. The MOMP21-387 fusion protein was puriifed and identiifed by SDS-PAGE and western blot analysis. The immu-nogenicity was further assessed by immunizing BABL/c mice, the reactivity of speciifc serum IgG in serum and genital tract mucosal IgA were tested by ELISA, and the speciifc cytotoxicity of spleen cells was detected with lactate dehydrogenase (LDH) method. Results:The MOMP21-387 fusion protein was successfully expressed in a prokaryotic expression system, and the speciifc positive bands at the relative molecular mass (Mr) of about 44 000 was conifrmed by SDS-PAGE and western blot analysis;And the puriifed MOMP21-387 fusion protein was ob-tained with the Ni-NTA afifnity chromatography method. The mice can be induced to produce the speciifc serum IgG and reproductive tract mucosal IgA by immunizing with the MOMP21-387 fusion protein, and the value of the speciifc serum IgG and mucosal IgAin immunized groups were signiifcantly higher than that of the PBS control group (P<0.05), the antibodys detected by ELISA reached peak at the 6th week post-immunization. The LDH analysis showed that, the killing rate of spleen cells to the target cell in MOMP21-387 protein immunized groups was signiifcantly higher than those in PBS control group, when the effector cells to target ratio reached to 10:1, 20:1, 40:1 and 80:1 (P<0.05). Conclusion:The MOMP21-387 fusion protein of Chlamydia trachomatis serovar E shows good immunogenicity, It may lay the foundation for the Chlamydia trachomatis ELISA detection and vac-cine development based on MOMP21-387.